|[January 02, 2013]
Navidea Biopharmaceuticals Announces Presentation at the 2013 Biotech Showcase™ Conference
DUBLIN, Ohio --(Business Wire)--
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical
company focused on precision diagnostic radiopharmaceuticals, today
announced that Dr. Mark Pykett, President and CEO of Navidea, will
present a business and program update during the 2013 Biotech Showcase
Conference to be held at the Parc 55 Wyndham-Union Square in San
Francisco, CA (News - Alert). Dr. Pykett will speak on Monday, January 7, 2013 at 10:00
AM PST. Investors and the public are invited to listen to a live webcast
of the presentation at http://www.media-server.com/m/p/8s39iw6x.
Following the conference, the webcast will be archived for approximately
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical
company focused on the development and commercialization of precision
diagnostics and radiopharmaceutical agents. Navidea is actively
developing four radiopharmaceutical agent platforms - Lymphoseek®,
NAV4694, NAV5001 and RIGScanTM - to help identify the sites
and pathways of undetected disease and enable better diagnostic
accuracy, clinical decision-making and, ultimately, patient care.
Navidea's strategy is to deliver superior growth and shareholder return
by bringing to market novel radiopharmaceutical agents and advancing the
Company's pipeline through selective acquisitions, global partnering and
commercialization efforts. For more information, please visit www.navidea.com.
About Biotech Showcase 2013
Biotech Showcase is an investor and partnering conference devoted to
providing private and public biotechnology and life sciences companies
an opportunity to present to, and meet with, investors and
pharmaceutical executives during the course of one of the industry's
largest annual healthcare investor conferences. Now in its fifth year,
Biotech Showcase is expected to attract upwards of 1,500 attendees.
Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and
EBD Group. Demy-Colton Life Science Advisors is focused exclusively on
facilitating the growth of the life science industry. EBD Group is the
leading partnering firm for the global life science industry.
[ InfoTech Spotlight's Homepage ]